Seattle Genetics
Merck & Co signs multi-billion cancer drug development deal with Seattle Genetics
Richard Staines
breast cancer, cancer, Merck & Co, Seattle Genetics
0 Comment
Seattle Genetics snags early approval for advanced breast cancer drug
Richard Staines
breast cancer, fda, Seattle Genetics, Tukysa
0 Comment
News/ News/ Oncology/ Top stories
FDA sets August action date for Seattle’s oral HER2 drug tucatinib
Phil Taylor
breast cancer, her2, Oncology, Priority Review, Seattle Genetics, tucatinib
0 Comment
Seattle Genetics says data backs Padcev combo for first-line bladder cancer
Phil Taylor
Astellas, bladder cancer, Oncology, Padcev, Seattle Genetics
0 Comment
News/ News/ Oncology/ Top stories
FDA backs Astellas/Seattle Genetics bladder cancer drug
Richard Staines
Astellas, bladder cancer, cancer, Padcev, Seattle Genetics
0 Comment
AZ and Daiichi Sankyo’s breast cancer drug delays progression in advanced disease
Richard Staines
AstraZeneca, breast cancer, Daiichi Sankyo, Seattle Genetics
0 Comment
News/ News/ Oncology/ Top stories
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Richard Staines
AstraZeneca, breast cancer, Daiichi Sankyo, Seattle Genetics
0 Comment
Seattle Genetics plans to file breast cancer drug tucatinib
Richard Staines
breast cancer, cancer, Roche, Seattle Genetics
0 Comment